Hans Stauss

9PUBLICATIONS

93CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGene and molecular therapyInnate immunityMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|May 20, 2026

Coupling dead cell recognition to Fcγ receptors augments anticancer immunity.

|Dec 05, 2025

LANA-specific CD4+ effector T cells accumulate at the site of KSHV infection in humanized mice.

Michelle Böni, Shitao Peng, Danusia Vanoaica

|Jun 29, 2023

Synthetic Cell-Based Immunotherapies for Neurologic Diseases.

Louisa von Baumgarten, Hans J Stauss, Jan D Lünemann

|Dec 02, 2021

An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease.

Yanchun Peng, Suet Ling Felce, Danning Dong

|May 15, 2021

Targeting human Acyl-CoA:cholesterol acyltransferase as a dual viral and T cell metabolic checkpoint.

Nathalie M Schmidt, Peter A C Wing, Mariana O Diniz

|Feb 25, 2021

Transitional B cell cytokines predict renal allograft outcomes.

Aravind Cherukuri, Alan D Salama, Rajil Mehta

Pageof 2

Frequent Collaborators

Benny Chain

Mirjam H M Heemskerk

Peter A C Wing

Rogier M Reijmers

Annemarie Woolston

Alan Kennedy

David Stirling

Louisa Green

David Jones

David A Price

Frequent Collaborators

Benny Chain

Mirjam H M Heemskerk

Peter A C Wing

Rogier M Reijmers